A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma
Clinical trial NCT07705308 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07705308
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-08-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.